Paradromics

Paradromics is a clinical-stage neurotechnology company headquartered in Austin, Texas, with a machine-learning and data-science office in Oakland, California, developing high-data-rate implantable brain-computer interfaces (BCI). Founded in 2019 by Matt Angle, the company builds the Connexus BCI, an investigational fully implantable system that records high-resolution intracortical neural activity and transmits it through the skin to an external system that decodes intended speech, text and digital device control for people with severe motor impairment. Connexus holds FDA Breakthrough Device Designations for speech decoding (2023) and digital device control (2024), was accepted into the FDA Total Product Life Cycle Advisory Program, and received an Investigational Device Exemption in November 2025 for the Connect-One Early Feasibility Study (ClinicalTrials.gov NCT07357428). Tempo BCI is a pre-clinical-trial pipeline product. Paradromics publishes no public developer API, SDK or machine-readable API contract; its only machine-readable public surface is an llms.txt AI-context file at paradromics.com/llms.txt.

Paradromics is profiled on the APIs.io network. Tagged areas include Company, Brain-Computer Interface, Neurotechnology, Medical Devices, and Health Care.

Paradromics’ developer surface includes engineering blog, product news, support, and 9 more developer resources.

🌐 Visit website 📡 Source on GitHub

13.1/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-05 · rubric v0.9.1

0 APIs

CompanyBrain-Computer InterfaceNeurotechnologyMedical DevicesHealth CareImplantable DevicesNeural DataAssistive TechnologyClinical ResearchArtificial Intelligence

Kin Score

Kin Score How this is scored →
scored 2026-08-05 · rubric v0.9.1

Composite quality — 13.1/100 · emerging

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.7 / 13

Governance 0.0 / 12

Discoverability 6.9 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/paradromics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Build 1

SDKs, sample code, and the tooling you integrate with

GitHubOrganization

GitHubOrganization

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 5

The organization behind the API

Website

About

Blog

BlogRSS

News

Other 1

Properties that don't map to a standard resource type

SecondaryMarket

SecondaryMarket

Source (apis.yml)

aid: paradromics
name: Paradromics
description: Paradromics is a clinical-stage neurotechnology company headquartered in Austin, Texas, with a machine-learning
  and data-science office in Oakland, California, developing high-data-rate implantable brain-computer interfaces (BCI). Founded
  in 2019 by Matt Angle, the company builds the Connexus BCI, an investigational fully implantable system that records high-resolution
  intracortical neural activity and transmits it through the skin to an external system that decodes intended speech, text
  and digital device control for people with severe motor impairment. Connexus holds FDA Breakthrough Device Designations
  for speech decoding (2023) and digital device control (2024), was accepted into the FDA Total Product Life Cycle Advisory
  Program, and received an Investigational Device Exemption in November 2025 for the Connect-One Early Feasibility Study (ClinicalTrials.gov
  NCT07357428). Tempo BCI is a pre-clinical-trial pipeline product. Paradromics publishes no public developer API, SDK or
  machine-readable API contract; its only machine-readable public surface is an llms.txt AI-context file at paradromics.com/llms.txt.
url: https://raw.githubusercontent.com/api-evangelist/paradromics/refs/heads/main/apis.yml
image: https://paradromics.com/wp-content/uploads/2026/07/Paradromics-Brain-Computer-Interface-Platform-Company.png
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment-pass
specificationVersion: '0.20'
created: '2026-08-02'
modified: '2026-08-02'
tags:
- Company
- Brain-Computer Interface
- Neurotechnology
- Medical Devices
- Health Care
- Implantable Devices
- Neural Data
- Assistive Technology
- Clinical Research
- Artificial Intelligence
apis: []
x-enrichment:
  date: '2026-08-02'
  status: enriched
  artifacts_added: 3
  pass: local-v1
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/paradromics-domain-security.yml
- type: Website
  url: https://paradromics.com/
- type: About
  url: https://paradromics.com/company/
- type: Blog
  url: https://paradromics.com/blog/
- type: BlogRSS
  url: https://paradromics.com/feed/
- type: News
  url: https://paradromics.com/news/
- type: Support
  url: https://paradromics.com/contact/
- type: GitHubOrganization
  url: https://github.com/paradromics
- type: TermsOfService
  url: https://paradromics.com/legal
- type: PrivacyPolicy
  url: https://paradromics.com/legal
- type: LLMsTxt
  url: llms/paradromics-llms.txt
- type: SecondaryMarket
  url: https://forgeglobal.com/paradromics_stock/